Fengcai Zhu
- Infectious Diseases top 0.2%
- Epidemiology top 1%
- Cardiology and Cardiovascular Medicine top 2%
- Molecular Biology top 10%
- Hepatology top 1%
- Topics
- SARS-CoV-2 and COVID-19 Research (69 papers)Viral gastroenteritis research and epidemiology (53 papers)Viral Infections and Immunology Research (50 papers)
- Cited by
- Infectious DiseasesHepatologyHealth
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Fengcai Zhu
231 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 3.6k
- Epidemiology 2.0k
- Cardiology and Cardiovascular Medicine 913
- Molecular Biology 791
- Hepatology 729
Countries citing papers authored by Fengcai Zhu
This map shows the geographic impact of Fengcai Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengcai Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengcai Zhu more than expected).
Fields of papers citing papers by Fengcai Zhu
This network shows the impact of papers produced by Fengcai Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengcai Zhu. The network helps show where Fengcai Zhu may publish in the future.
Co-authorship network of co-authors of Fengcai Zhu
This figure shows the co-authorship network connecting the top 25 collaborators of Fengcai Zhu. A scholar is included among the top collaborators of Fengcai Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengcai Zhu. Fengcai Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trialsbreakdown → | 68 |
| 7 | 1 | |
| 8 | 23 | |
| 9 | 1 | |
| 10 | 18 | |
| 11 | 15 | |
| 12 | 1 | |
| 13 | 24 | |
| 14 | 18 | |
| 15 | 40 | |
| 16 | 51 | |
| 17 | 1 | |
| 18 | 2 | |
| 19 | [Epidemiological characteristics of enterovirus type 71 diseases]. | 1 |
| 20 | 3 |
About Fengcai Zhu
Fengcai Zhu is a scholar working on Infectious Diseases, Hepatology and Health, having authored 240 papers that have together received 6.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (69 papers), Viral gastroenteritis research and epidemiology (53 papers) and Viral Infections and Immunology Research (50 papers). The work is most often cited by research in Infectious Diseases (3.6k citations), Hepatology (729 citations) and Health (673 citations). Fengcai Zhu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jingxin Li, Lunbiao Cui, Hongxing Pan, Kai Chu, Yiyue Ge, Baoli Zhu, Bin Wu, Zhenglun Liang, Changgui Li and Yuemei Hu. Their work appears in journals such as New England Journal of Medicine, The Lancet and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.